February 2005 Research News
Primary Therapy in Early Breast Cancer Conference
This month's Research News provides easy-to-understand summaries of some of the most important research advances reported at an international conference of breast cancer experts held January 26–29, 2005. We also have information about a new formulation of the drug paclitaxel for treating advanced disease.
The Primary Therapy in Early Breast Cancer Conference, held in St. Gallen, Switzerland, presented research on many breast cancer–related areas, including hormonal therapy, quality of life, and new nipple-sparing surgery.
Read more about these important topics, as well as about Abraxane, a new treatment for advanced disease:
- Fewer Side Effects with Sentinel Lymph Node Removal
- First Attempts to Perform New Nipple-Saving Mastectomy Surgery
- Femara Better than Tamoxifen in Reducing Recurrence in Early-Stage Breast Cancer
- Abraxane Better than Taxol for Advanced Breast Cancer
To learn more about the advances discussed at the 2005 St. Gallen Conference, read the transcript from our February 2005 Ask-the-Expert Online Conference on this topic.
The February 2005 Research News section was made possible by an unrestricted educational grant from Novartis Oncology.
An original video-on-demand educational initiative brought to you by Breastcancer.org and Comcast. Visit www.comcast.net/pinkribbon each week through the end of October for engaging, up-to-date videos and information about the fight to end breast cancer.